307 related articles for article (PubMed ID: 19286653)
1. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
Chernov AV; Sounni NE; Remacle AG; Strongin AY
J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
[TBL] [Abstract][Full Text] [Related]
2. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
3. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
4. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
5. Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.
Sounni NE; Rozanov DV; Remacle AG; Golubkov VS; Noel A; Strongin AY
Int J Cancer; 2010 Mar; 126(5):1067-78. PubMed ID: 19551841
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
7. In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.
Paquette B; Baptiste C; Therriault H; Arguin G; Plouffe B; Lemay R
Br J Cancer; 2007 Dec; 97(11):1505-12. PubMed ID: 17987037
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
9. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
[TBL] [Abstract][Full Text] [Related]
10. Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 responses to traumatic skeletal muscle injury.
Barnes BR; Szelenyi ER; Warren GL; Urso ML
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1501-8. PubMed ID: 19794148
[TBL] [Abstract][Full Text] [Related]
11. Individual Timp deficiencies differentially impact pro-MMP-2 activation.
English JL; Kassiri Z; Koskivirta I; Atkinson SJ; Di Grappa M; Soloway PD; Nagase H; Vuorio E; Murphy G; Khokha R
J Biol Chem; 2006 Apr; 281(15):10337-46. PubMed ID: 16469749
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
13. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
14. Investigating the expression of MMPs and TIMPs in preterm placenta and role of CpG methylation in regulating MMP-9 expression.
Sundrani D; Narang A; Mehendale S; Joshi S; Chavan-Gautam P
IUBMB Life; 2017 Dec; 69(12):985-993. PubMed ID: 29130646
[TBL] [Abstract][Full Text] [Related]
15. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
16. Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.
Niarakis A; Giannopoulou E; Ravazoula P; Panagiotopoulos E; Zarkadis IK; Aletras AJ
FEBS J; 2013 Dec; 280(24):6541-55. PubMed ID: 24112707
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
18. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
19. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
20. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
